OTCMKTS:AKAOQ Achaogen (AKAOQ) Stock Price, News & Analysis $0.03 +0.00 (+0.81%) As of 06/18/2021 Add Compare Share Share Stock Analysis Stock Analysis About Achaogen Stock (OTCMKTS:AKAOQ) Get Achaogen alerts:Sign Up Key Stats Today's Range$0.02▼$0.0350-Day Range$0.03▼$0.0352-Week Range$0.00▼$0.05Volume68,500 shsAverage Volume186,196 shsMarket Capitalization$1.21 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Achaogen, Inc. was a biopharmaceutical company focused on developing and commercializing antibiotics for serious, drug-resistant bacterial infections. The company’s research programs centered on aminoglycoside antibiotics and other treatments intended to address infections caused by multidrug-resistant pathogens. Achaogen’s principal product was plazomicin, marketed in the United States as ZEMDRI. The U.S. Food and Drug Administration approved ZEMDRI in 2018 for the treatment of adults with complicated urinary tract infections, including kidney infections, caused by certain susceptible Enterobacteriaceae bacteria. The company also maintained earlier-stage antibacterial research programs. Achaogen was founded in 2002 and was based in South San Francisco, California. After experiencing commercial and financial challenges, the company filed for Chapter 11 bankruptcy protection in 2019. Its assets and rights related to plazomicin were subsequently acquired by Cipla USA. Achaogen is no longer operating as an independent publicly traded company.AI Generated. May Contain Errors. Read More Receive AKAOQ Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Achaogen and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AKAOQ Stock News Headlines‘Sword Of The Demon Hunter’ Anime: Plot, Voice Cast, Teaser Trailer And Release DateMay 14, 2024 | msn.comSee More Headlines AKAOQ Stock Analysis - Frequently Asked Questions How have AKAOQ shares performed this year? Achaogen's stock was trading at $0.0250 at the start of the year. Since then, AKAOQ shares have increased by 0.0% and is now trading at $0.0250. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:AKAOQ CIKN/A Webwww.achaogen.com Phone650-800-3636FaxN/AEmployees42Year Founded2004Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$8.73 million Price / Sales0.14 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares48,210,000Free FloatN/AMarket Cap$1.21 million OptionableNot Optionable Beta-0.81 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:AKAOQ) was last updated on 6/18/2021 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. O...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achaogen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Achaogen With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
